Founders Grove Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Sell
8,167
-67
-0.8% -$15.6K 0.45% 50
2025
Q4
$1.7M Buy
8,234
+954
+13% +$189K 0.38% 56
2025
Q3
$1.35M Buy
7,280
+686
+10% +$118K 0.32% 60
2025
Q2
$1.01M Sell
6,594
-292
-4% -$44.9K 0.25% 70
2025
Q1
$1.14M Buy
6,886
+168
+3% +$26.3K 0.32% 64
2024
Q4
$972K Buy
+6,718
New +$1.04M 0.28% 71

Other funds holding JNJ

Founders Grove Wealth Partners's JNJ Position: Q1 2026 in Review

Founders Grove Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 0.81% in Q1 2026, selling an estimated $15.6K and leaving 8,167 shares worth $2M. The position accounts for 0.45% of the portfolio, ranked #50.

Founders Grove Wealth Partners first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Founders Grove Wealth Partners held 8,167 shares of Johnson & Johnson worth $2M as of Q1 2026.
  • Founders Grove Wealth Partners sold 67 Johnson & Johnson shares in Q1 2026, an estimated $15.6K.
  • Johnson & Johnson made up 0.45% of Founders Grove Wealth Partners's portfolio in Q1 2026, its #50 holding.
  • Founders Grove Wealth Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Founders Grove Wealth Partners's 13F filing for Q1 2026, filed 15 Apr 2026.